 Salvage chemotherapy patients germ cell tumors Memorial Sloan-Kettering Cancer Center experience germ cell tumor GCT patients successive platin-based induction regimens durable complete response CR alive median follow-up months analysis prognostic factors response survival patients salvage chemotherapy Survival and/or response therapy patients prior CR chemotherapy treatment cisplatin-based salvage regimen testis primary site normal serum human chorionic gonadotropin level normal serum lactate dehydrogenase level site metastasis Indiana Class Patients prior incomplete response IR poor prognosis patients alive median follow-up months patients prior response CR median follow-up months poor survival patients durable CR chemotherapy warrants continued investigation new salvage therapy identification prognostic features salvage therapy aid interpretation clinical trials salvage regimens